MYC and lymphoma: Evasion of immune surveillance in lymphomas overexpressing MYC was first described in 1985, when Epstein-Barr virus (EBV) positive B cell NHL cell lines harboring an MYC translocation were found insensitive to cytotoxic T cell responses, irrespective of antigen expression [43].